Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Autoinjectors Market from 2024 to 2025?

The dimension of the autoinjectors market has significantly expanded in the past years. The market value is set to rise from $3.7 billion in 2024 to $4.55 billion in 2025, showing a compound annual growth rate (CAGR) of 22.8%. Factors contributing to this growth during the historic period include the increasing incidence of chronic illnesses, the expanding aged population, growth in the biotechnology and pharmaceutical industry, a surge in the preference for self-administration by patients, and regulatory backing.

What Is the Projected Market Size of the Autoinjectors Market?

In the coming years, the autoinjectors market is projected to experience remarkable expansion. The market’s value is anticipated to reach $10.07 billion by 2029, growing at a compound annual growth rate (CAGR) of 22.0%. The expected growth within the projected period can be attributed to the development in therapeutic applications, escalating healthcare expenses, a heightened emphasis on patient-centric care, the rise of telemedicine and remote patient monitoring, and newly emerging markets. Key trends that are to be observed throughout the forecast period include customized drug delivery, intelligent and interconnected autoinjectors, autoinjectors that don’t require needles, the delivery of biologic drugs, and the inclusion of safety and security features.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5249&type=smp

Who are the Major Competitors in the Autoinjectors Market Outlook?

Major companies operating in the autoinjectors market include AbbVie Inc., Mylan N.V., Eli Lilly and Company, Amgen Inc., Becton, Dickinson and Company, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Pfizer Inc., Bayer AG, Biogen Inc., AstraZeneca PLC, Haselmeier GmbH, Owen Mumford Ltd., Gerresheimer AG, Philip Morris International Inc., Oval Medical Technologies Ltd., Solteam Incorporation Co. Ltd., Elcam Medical Group (E3D) Ltd., Jabil Inc., Catalent Inc., SHL Medical AG, West Pharmaceutical Services Inc., Nemera Development S.A., Bespak Europe Ltd., AptarGroup Inc., Consort Medical plc, Terumo Corporation, Nipro Corporation, Medtronic plc, Integra LifeSciences Corporation, OssDsign AB, Xenco Medical LLC, Renishaw plc

What Is Fueling Growth in the Autoinjectors Market?

The expected rise in chronic diseases is predicted to propel the expansion of the autoinjectors market in the future. Chronic diseases can be defined as conditions that persist for a year or more, requiring ongoing medical care. Major contributors to global morbidity and mortality include chronic diseases like heart disease, cancer, rheumatoid arthritis, and diabetes. Autoinjectors are designed for repeated injections of biologics and hormones in patients needing consistent dosages for the long-term control of conditions such as diabetes and rheumatoid arthritis. For example, in a study conducted by the American Cancer Society in January 2022, it was anticipated that the US would see approximately 609,360 cancer deaths and 1.9 million new cases of cancer in 2022, which equates to around 1,670 deaths each day. The expanding occurrence of chronic diseases necessitates the growth of the autoinjectors market, given that these devices offer a comfortable and efficient option for patients requiring regular medications.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=5249&type=smp

Which Autoinjectors Market Segments Are Growing the Fastest?

The autoinjectors market covered in this report is segmented –

1) By Type: Disposable Autoinjectors, Reusable Autoinjectors

2) By Therapy: Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Other Therapies

3) By Route Of Administration: Subcutaneous, Intramuscular

4) By Distribution Channel: Online Retailer, Pharmacy

5) By End User: Home Care Settings, Hospitals And Clinics, Other End-Users

Subsegments:

1) By Disposable Autoinjectors: Single-Use Disposable Autoinjectors, Pre-filled Disposable Autoinjectors

2) By Reusable Autoinjectors: Multi-Use Reusable Autoinjectors, Rechargeable Reusable Autoinjectors

Which Industry Trends Are Shaping the Future of the Autoinjectors Market?

The rise of technological innovation is playing a significant role in the evolution of the autoinjectors market. The key players in this industry are actively striving to generate technological solutions for autoinjectors in order to satisfy the need for a viscous biologics delivery mechanism. For example, in May 2023, the Germany-based pharmaceutical firm Boehringer Ingelheim received U.S. Food and Drug Administration (FDA) authorisation for its Cyltezo Pen, an autoinjector version of Cyltezo (adalimumab-adbm) which is approved for treating several chronic inflammatory ailments. The 40 mg/0.8 mL pre-loaded Cyltezo Pen will be available in two, four, and six-pack formats.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/autoinjectors-global-market-report

Which Countries Are Leading the Autoinjectors Market?

North America was the largest region in the autoinjectors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the autoinjectors market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5249

This Report Delivers Insight On:

1. How big is the autoinjectors market, and how is it changing globally?

2. Who are the major companies in the autoinjectors market, and how are they performing?

3. What are the key opportunities and risks in the autoinjectors market right now?

4. Which products or customer segments are growing the most in the autoinjectors market?

5. What factors are helping or slowing down the growth of the autoinjectors market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model